The Medical Travel Company (TMTC) has successfully completed a funding round totaling EUR 38 million. This significant investment aims to propel the advancement of TMTC’s medical solutions.
TMTC operates in the medical travel sector, connecting patients with healthcare providers and facilitating international medical journeys. The company’s core offering involves providing comprehensive solutions for individuals seeking medical treatment abroad.
The recent funding round is expected to support TMTC’s growth and development initiatives. This includes enhancing its existing medical solutions and potentially expanding its services. The exact nature of these advancements or expansions is not detailed in the provided information.
The article does not specify the date of the funding round beyond the publication date of the article itself (October 7, 2025). It also does not name the investors who participated in this round.
Key Points
* Funding Round Total: EUR 38 million
Read the Complete Article.

































